Sunitinib and Reversible Posterior Leukoencephalopathy Syndrome: the usual suspect but not always the culprit. A case report.
Authors
Ourania Katopodis
Department of Medical Oncology, Euroclinic of Athens, Athens, Greece
Maria Lerikou
Department of Medical Oncology, Euroclinic of Athens, Athens, Greece
Georgios Karagiorgis
Department of Neurology, Euroclinic of Athens, Athens, Greece
Spyridon Arvanitakis
Department of Medical Oncology, Euroclinic of Athens, Athens, Greece
Language: English
Page range: 14 - 18
Submitted on: Jul 17, 2024
Accepted on: Nov 13, 2024
Published on: Apr 15, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2025 Ourania Katopodis, Maria Lerikou, Georgios Karagiorgis, Spyridon Arvanitakis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.